Company
Outpace Bio, Inc.
Outpace Bio, Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| OPB-201 | Phase 1 | Endometrial Cancer Recurrent |
Latest
No recent events.
Follow Outpace Bio, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.